4.5 Article

Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study

期刊

BMJ-BRITISH MEDICAL JOURNAL
卷 346, 期 -, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmj.f2350

关键词

-

资金

  1. UK National Institute for Health Research [RP-PG-0407-10314]
  2. Wellcome Trust [086091/Z/08/Z, 098504, 0938/30/Z/10/Z]
  3. UK Biobank
  4. Medical Research Council
  5. Healthcare products Regulatory Agency
  6. National Institute for Health Research health technology assessment programme
  7. Innovative Medicine Initiative
  8. UK Department of Health
  9. Technology Strategy Board
  10. EU
  11. GlaxoSmithKline
  12. Novo Nordisk
  13. Dutch Medicines Evaluation Board
  14. Dutch Ministry of Health
  15. ESRC [ES/L007517/1] Funding Source: UKRI
  16. Economic and Social Research Council [ES/L007517/1] Funding Source: researchfish
  17. Medical Research Council [MR/K006584/1] Funding Source: researchfish
  18. National Institute for Health Research [RP-PG-0407-10314, NF-SI-0510-10090] Funding Source: researchfish
  19. National Institutes of Health Research (NIHR) [RP-PG-0407-10314] Funding Source: National Institutes of Health Research (NIHR)

向作者/读者索取更多资源

Objective To determine the completeness and diagnostic validity of myocardial infarction recording across four national health record sources in primary care, hospital care, a disease registry, and mortality register. Design Cohort study. Participants 21 482 patients with acute myocardial infarction in England between January 2003 and March 2009, identified in four prospectively collected, linked electronic health record sources: Clinical Practice Research Datalink (primary care data), Hospital Episode Statistics (hospital admissions), the disease registry MINAP (Myocardial Ischaemia National Audit Project), and the Office for National Statistics mortality register (cause specific mortality data). Setting One country (England) with one health system (the National Health Service). Main outcome measures Recording of acute myocardial infarction, incidence, all cause mortality within one year of acute myocardial infarction, and diagnostic validity of acute myocardial infarction compared with electrocardiographic and troponin findings in the disease registry (gold standard). Results Risk factors and non-cardiovascular coexisting conditions were similar across patients identified in primary care, hospital admission, and registry sources. Immediate all cause mortality was highest among patients with acute myocardial infarction recorded in primary care, which (unlike hospital admission and disease registry sources) included patients who did not reach hospital, but at one year mortality rates in cohorts from each source were similar. 5561 (31.0%) patients with non-fatal acute myocardial infarction were recorded in all three sources and 11 482 (63.9%) in at least two sources. The crude incidence of acute myocardial infarction was underestimated by 25-50% using one source compared with using all three sources. Compared with acute myocardial infarction defined in the disease registry, the positive predictive value of acute myocardial infarction recorded in primary care was 92.2% (95% confidence interval 91.6% to 92.8%) and in hospital admissions was 91.5% (90.8% to 92.1%). Conclusion Each data source missed a substantial proportion (25-50%) of myocardial infarction events. Failure to use linked electronic health records from primary care, hospital care, disease registry, and death certificates may lead to biased estimates of the incidence and outcome of myocardial infarction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据